Template:Bleeding: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
No edit summary |
||
| (5 intermediate revisions by one other user not shown) | |||
| Line 29: | Line 29: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
:[[Bleeding Academic Research Consortium]] | : [[Bleeding Academic Research Consortium]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
:[[TIMI bleeding criteria]] | : [[TIMI bleeding criteria]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
:[[GUSTO bleeding criteria]] | : [[GUSTO bleeding criteria]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
:[[CURE bleeding criteria]] | : [[CURE bleeding criteria]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
:[[ACUITY HORIZONS bleeding criteria]] | : [[ACUITY HORIZONS bleeding criteria]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
:[[STEEPLE bleeding criteria]] | : [[STEEPLE bleeding criteria]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
:[[PLATO bleeding criteria]] | : [[PLATO bleeding criteria]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
:[[GRACE bleeding criteria]] | : [[GRACE bleeding criteria]] | ||
|- | |- | ||
! | ! | ||
| Line 82: | Line 82: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
| Line 95: | Line 94: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
: [[ | : [[Bleeding perioperative bleeding anemia management|Anemia Management]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
: [[ | : [[Bleeding perioperative bleeding monitoring of coagulation status and platelet function|Coagulation Monitoring]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
: [[ | : [[Bleeding perioperative bleeding coagulation management|Coagulation Management]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy|Discontinuation, Bridging, and Reversal of Anticoagulation and Antiplatelet Therapy]] | : [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy|Discontinuation, Bridging, and Reversal of Anticoagulation and Antiplatelet Therapy]] | ||
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Antiplatelet Agents|Antiplatelet Agents]] | |||
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Heparin|Heparin]] | |||
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Fondaparinux|Fondaparinux]] | |||
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Vitamin K Antagonists|Vitamin K Antagonists]] | |||
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#New Oral Anticoagulants|New Oral Anticoagulants]] | |||
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Comorbidities Involving Hemostatic Derangement|Comorbidities Involving Hemostatic Derangement]] | |||
|- | |- | ||
! | ! | ||
Latest revision as of 13:10, 25 April 2014
|
Bleeding Microchapters |
|
Treatment |
|---|
|
Reversal of Anticoagulation and Antiplatelet in Active Bleed |
|
Perioperative Bleeding |
|
Bleeding On the Web |
|
American Roentgen Ray Society Images of Bleeding |